In the article "Oral Physostigmine Treatment of Patients With Alzheimer's Disease" by Richard C. Mohs, Ph.D., et al., in the January 1985 issue, in table 1 on page 30, the replication ADAS score during placebo administration for patient 3 should have been 66.2. The percent change in replication ADAS score for patient 2 should have been 19.1; for patient 6 it should have been 4.5; and for patient 7 it should have been 3.5. The staff regrets these errors.
Abstract Teaser